About this trial
This national, multicenter, prospective cohort study aims to determine the prevalence and risk factors associated with major peri-intubation complications in critically ill adult patients undergoing tracheal intubation in intensive care units (ICUs), and to compare these findings with those previously reported in the INTUPROS 1 study. Additionally, the study will evaluate the impact of a structured educational intervention on airway management practices and clinical outcomes through a pre- and post-intervention design
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing tracheal intubation in ICU
Disqualifiers
Intubation outside ICU
Cardiac arrest at time of intubation
Trial population
Patients intubated in the ICU
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Major peri-intubation complications
Number and proportion of patients experiencing at least one major peri-intubation complication during tracheal intubation in the intensive care unit. Major peri-intubation complications include cardiovascular instability, severe hypoxemia, cardiac arrest requiring resuscitation, and death. Risk factors independently associated with major peri-intubation complications will also be analyzed, and the results will be compared with those previously reported in the INTUPROS 1 study.
Secondary outcomes
First-pass intubation success
Number and proportion of patients in whom successful tracheal intubation is achieved on the first intubation attempt. The first-pass intubation success rate will be compared with that previously reported in the INTUPROS 1 study.
Use of videolaryngoscopy and type of videolaryngoscope
Number and proportion of tracheal intubations in which videolaryngoscopy is used. The type of videolaryngoscope used and its order of use during the intubation procedure will also be recorded.
Pharmacological agents used to facilitate tracheal intubation
Number and proportion of patients receiving each pharmacological agent used to facilitate tracheal intubation. The agents used and their doses will be recorded, and patterns of pharmacological agent use will be compared with those previously reported in the INTUPROS 1 study.
Predictive performance of the INTUPROS difficult airway prediction score
Predictive performance for difficult tracheal intubation of the difficult airway prediction score derived from the INTUPROS 1 database. The prediction score does not include the MACOCHA score.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Spanish Society of Critical Care Medicine and Coronary Units
Lead sponsor
Hospitales Universitarios Virgen del Rocío
Collaborator
Henares University Hospital
Collaborator
Hospital San Juan de Dios del Aljarafe de Sevilla
Collaborator
Hospital Mutua de Terrassa
Collaborator
This trial is not recruiting at the moment. You can still explore other options: